ADARB2 and Alzheimer disease: While ADARB2-AS1 showed downregulation in AD in the GSE184942 dataset (− 0.89 ± 0.39), ENSG00000260573 showed significant upregulation in both the GSE184942 (2.68 ± 1.28) and GSE173955 (1.79 ± 0.83) datasets in AD (Supplementary Table S12).